Antonio Passaro
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
Antonio Passaro
Apr 23, 2024, 20:12 |
Blog
Antonio Passaro: An honor to have been a part of this significant manuscript, just out in Annals of Oncology driving forward the clinical development of ADCs
Antonio Passaro, Medical Director with Highly Specialized Position at IEO European Institute of Oncology, shared on…
Apr 23, 2024, 11:38 |
Insight
Antonio Passaro: ETOP IBCSG Partners Foundation's position statement on antibody-drug conjugates (ADC) in lung and breast cancer
Antonio Passaro, Lung cancer Oncologist and Researcher at IEO, recently shared on X: "Just out…
Apr 21, 2024, 18:13 |
Blog
Antonio Passaro: An intense yet incredibly rewarding day in Oporto
Antonio Passaro, Medical Director with Highly Specialized Position at IEO European Institute of Oncology, shared a…
Apr 15, 2024, 13:28 |
Insight
Antonio Passaro: Release of our editorial, co-authored with Peters Solange, focusing on the groundbreaking ALINA study
Antonio Passaro, Medical Oncologist at European Institute of Oncology, shared on LinkedIn: ''I am thrilled…
Apr 15, 2024, 01:09 |
Blog
Antonio Passaro: Our editorial on the groundbreaking ALINA trial
Antonio Passaro, Medical Oncologist at European Institute of Oncology, shared on X/Twitter: "Just published in…
Apr 8, 2024, 16:54 |
Blog
Antonio Passaro: The phase 3 KRYSTAL-12 trial represents a significant advancement in our understanding and treatment of KRAS-mutated NSCLC
Antonio Passaro, Medical Oncologist at European Institute of Oncology, shared a post on LinkedIn: "Why…
Apr 6, 2024, 07:14 |
Drugs
Antonio Passaro: Why is this press release of Bristol Myers Squibb so crucial for our community?
Antonio Passaro, Medical Director at the Institute of European Oncology (IEO), shared a post on…
Apr 2, 2024, 12:50 |
Blog
Antonio Passaro: Key milestones in cancer biomarker research and future avenues for enhancing the management of patients with solid tumors
Antonio Passaro, Medical Oncologist at the European Institute of Oncology, shared a post on LinkedIn:…
Mar 25, 2024, 15:15 |
Societies
25 Posts Not To Miss From ELCC 2024
The European Lung Cancer Congress (ELCC 2024) took place in Prague, Czech Republic, from 20th…
Jan 27, 2024, 22:56 |
Blog
Antonio Passaro: This scientific journey has not only been immensely interesting but exceptionally fruitful
Antonio Passaro, Medical Oncologist at the European Institute of Oncology, shared on LinkedIn: "Delighted to…
1
2
All:
13
Posts:
1 - 10
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Barbara Jereczek-Fossa has been elected as the ESTRO President-elect!
Neuroendocrine tumors - newly updated AJCC guidelines
5 min Sarcoma Talk with Shushan Hovsepyan and Andrea Ferrari
Facebook
RSS Feed
Twitter
Linkedin
Youtube